Wilson Sonsini Goodrich & Rosati's legacy closely traces the birth and evolution of Silicon Valley.
For six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
News and Featured Insights
Leading Matters
Client Highlights
Wilson Sonsini Advises Frete.com on $200 Million Series F
On November 10, 2021, Frete.com announced the close of a $200 million funding round led by SoftBank and Tencent. The round brings the Brazil-based Frete.com to a valuation worth over $1 billion. The platform uses digital software to help shippers and carriers to increase safety and productivity when hiring operators. The digital dashboard also reduces paperwork and increases the safety of both goods and carriers through real-time monitoring. With the capital, Frete.com aims to invest in product development and technology to improve the match between cargo and trucks, increase safety, reduce paperwork, and make the ecosystem more sustainable.
Client Highlights
Wilson Sonsini Advises Density on $125 Million Series D Funding
On November 10, 2021, Density Inc., the leading analytics platform for measuring and optimizing workplace performance, announced it has secured $125 million in Series D funding led by existing investor Kleiner Perkins. Other new investors include Altimeter Capital and Lachy Groom of LGF, with participation from existing investors 01 Advisors, Upfront Ventures, and Founders Fund. Density will use the funds to grow its global team and support its rapidly expanding customer base. Altogether, Density has secured more than $225 million in funding since its founding, which brings its present valuation to $1.05 billion.
Client Highlights
Wilson Sonsini Advises Fieldwire in Its Acquisition by Hilti Group
On November 16, 2021, Hilti Group, a global leader in innovative tool and fastening solutions, technology, software, and services for the commercial construction industry, announced that it has entered into an agreement to acquire Fieldwire, a San Francisco-based construction technology company, for an approximate $300 million. The strategic acquisition will bring together Fieldwire's best-in-class product and Hilti's global brand and market reach to help drive productivity at contractors and on construction sites. Wilson Sonsini Goodrich & Rosati represented Fieldwire in the transaction.
Client Highlights
Wilson Sonsini Advises Kedalion on Series B Funding, Signing of Option to Acquire Agreement
On November 15, 2021, Kedalion Therapeutics announced the completion of its Series B financing led by Novartis and involving a combination of new and existing investors. The Novartis investment includes an exclusive option to acquire the company and its AcuStream technology. The agreement follows a feasibility study agreement with the AcuStream technology signed earlier this year. The subsequent feasibility study has been completed with successful results. Collaboration between the two parties is ongoing. The financial and other terms of this transaction have not been disclosed.
Client Highlights
Wilson Sonsini Advises Podium on $201 Million Series D Round
On November 15, 2021, Podium, a communication and payments platform for local businesses, announced it has raised $201 million in Series D funding, led by YC Continuity with participation from Durable Capital Partners, Arpex Capital, Accel, Album VC, IVP, Sapphire Ventures, Summit Partners, and Sorenson Capital. This latest round brings the company's valuation to over $3 billion. Wilson Sonsini Goodrich & Rosati represented Podium in the transaction.
Client Advisories
Wilson Sonsini Advises Combangio in Its Acquisition by Kala Pharmaceuticals
On November 15, 2021, Kala Pharmaceuticals, a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye, announced that it has acquired Combangio, a private, clinical-stage company developing regenerative biotherapies for severe ocular surface diseases. Combangio is developing CMB-012, a novel investigational secretome therapy, now known as KPI-012, to address the complex wound healing process in persistent corneal epithelial defect (PCED) and other severe ocular diseases driven by impaired corneal healing. Wilson Sonsini Goodrich & Rosati represented Combangio in the transaction.
The Entrepreneurs Report - Q3 2021
In this latest issue of The Entrepreneurs Report, we’ve compiled a range of data on venture financing transactions in which the firm was involved during Q3 2021, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general. This edition also highlights the firm’s partnership with Morgan Stanley at Work to integrate Shareworks into Neuron; our recent announcement about a new Salt Lake City office; and data from Beauhurst—a searchable database of the UK's high-growth companies—on UK equity investment in Q3 2021.